Cochlear

Cochlear Equity Ratio

The Equity Ratio of Cochlear (COH.AX) as of Sep 27, 2026 is 66.87 %. In the previous year, Equity Ratio was 69.04 % — a change of -3.14% (lower).

Equity Ratio

66.87 %

YoY

-3.14%

Last updated:

Equity Ratio of Cochlear is 2026 66.87 % . Equity Ratio of Cochlear was 2025 69.04 % . It decreases by -3.14% lower compared to the previous year.

The Cochlear Equity Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Ratio
Date
Equity Ratio
Jan 1, 2019
52.63 AUD
Jan 1, 2020
54.26 AUD
Jan 1, 2021
69.64 AUD
Jan 1, 2022
68.38 AUD
Jan 1, 2023
68.08 AUD
Jan 1, 2024
67.05 AUD
Jan 1, 2025
69.04 AUD
Jan 1, 2026
66.87 AUD
The Cochlear Equity Ratio history
YEAREquity RatioYoY
66.87 %-3.14%
69.04 %+2.97%
67.05 %-1.52%
68.08 %-0.44%
68.38 %-1.81%
69.64 %+28.36%
54.26 %+3.09%
52.63 %-0.31%
52.80 %+10.36%
47.84 %+2.10%
46.85 %+15.41%
40.60 %-2.70%
41.72 %—
Access this data via the Eulerpool API

Cochlear Stock analysis

What does Cochlear do? Cochlear Ltd is an Australian-based medical technology company founded in 1981 by engineer Professor Graeme Clark. The company specializes in Cochlear implant systems and other hearing devices. Cochlear Ltd offers accessories, services, and rehabilitation training for individuals with hearing impairments. The company's products are available for both children and adults with varying degrees of hearing loss. Cochlear Ltd operates in different sectors, including Cochlear implant systems, hearing aids, and wireless accessories and streaming systems under the brand names Nucleus® and Baha®. Nucleus® systems utilize a fully implantable cochlear implant and external speech processor to convert sound into electrical signals for interpretation by the brain. Baha® systems are bone-anchored hearing devices for individuals with unilateral to moderate hearing impairments. Cochlear Ltd also provides wireless accessories and streaming systems to connect devices like mobile phones, TVs, and music players to the hearing aids and cochlear implants, improving hearing performance and enhancing social lives. The company has a strong global presence, operating in over 100 countries with headquarters in Australia, multiple production facilities, and research centers. Cochlear Ltd has received numerous awards and recognition for its products and services and is committed to researching and developing new therapies and technologies to improve the lives of individuals with hearing impairments. Cochlear is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cochlear stock

Equity Ratio of Cochlear is 66.87 % in 2026.

Equity Ratio of Cochlear changed from 69.04 % to 66.87 %, representing a -3.14% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Equity Ratio Cochlear since 2006 – with annual values, charts, and detailed analysis.

The equity ratio measures the proportion of total assets financed by shareholders' equity. Higher ratios indicate stronger financial independence and lower leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Ratio's Cochlear with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Cochlear

All Key Metrics — Cochlear